Skip to content

Major depressive disorder iTBS intervention and mechanism based on the personalized PFC-NAc loop of anhedonia.

Major depressive disorder iTBS intervention and mechanism based on the personalized PFC-NAc loop of anhedonia.

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097466
Enrollment
Unknown
Registered
2025-02-19
Start date
2024-06-14
Completion date
Unknown
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depression disorder

Interventions

iTBS-Active group:Use of transcranial magnetic stimulation (TMS) iTBS in the treatment of patients with anhedonia depression
iTBS-Sham group:Use of transcranial magnetic stimulation (TMS) iTBS in the treatment of patients with anhedonia depression
Healthy control:None

Sponsors

Sixth People's Hospital of Hebei Province (Hebei Provincial Mental Health Center)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-55 years; 2. Diagnosis of depression by more than two psychiatric attending physicians who understand and collaborate with this study according to the DSM-5 and screened by The Mini International Neuropsychiatric Interview (MINI) Fifth Edition; 3. Hamilton Depression Rating Scale-17 items (HAMD-17) > 17 points; 4. Psychiatrist assessed that there are obvious symptoms of anhedonia; 5. Dimensional Anhedonia Scale (DARS) self-rated total score 28 points; Current and prior use of CNS medications; right-handed; Understand the purpose of this study, be willing to participate, and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications to rTMS treatment; 2.Patients with contraindications to fMRI scanning; 3. Lifetime or current diagnosis of other mental disorders based on DSM-5 axis I; 4. Depression caused by other psychoactive substances and independent substances; 5. Severe suicidal tendency or recent suicidal behavior; 6. Received rTMS treatment before enrollment or electroconvulsive therapy in the past six months, or had no response to the above treatment methods; 7. Long-term use of high-dose benzodiazepines (lorazepam > 2mg/ day or equivalent; 8. Moderate or above abnormal electroencephalogram; 9. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Rating Scale score;Dimensional Anhedonia Rating Scale score;

Secondary

MeasureTime frame
Sneth Hamilton Pleasure Scale score;

Countries

China

Contacts

Public ContactWang Qi; Li Keqing

Sixth People's Hospital of Hebei Province (Hebei Provincial Mental Health Center)

wqi_115@163.com+86 177 1326 0069

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026